Basalog biosimilar insulin glargine regulatory update

Japan approved Biocon’s Basalog, a biosimilar of diabetes drug Lantus insulin glargine from Sanofi (Euronext:SAN; NYSE:SNY, Paris, France). Biocon expects to launch the product this quarter. Biocon ...